U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX19638275: GSM7092431: 53371 (WT); Mus musculus; RNA-Seq
1 ILLUMINA (NextSeq 500) run: 16.6M spots, 2.5G bases, 903.6Mb downloads

External Id: GSM7092431_r1
Submitted by: Department of Oncology, Barbara Ann Karmanos Cancer Institute Wayne State University School of Medicine
Study: The Janus kinase 1 is critical for the postnatal development of the pancreas and cancer progression
show Abstracthide Abstract
Inflammatory cytokines promote the development of pancreatic ductal adenocarcinoma (PDAC), but the functions of specific intracellular signaling mediators in this process are less well-defined. In this study, we discovered that the Janus kinase 1 (JAK1) is critical for the early postnatal growth of the exocrine pancreas. Using a ligand-controlled and pancreas-specific knockout in adult mice, we demonstrate that JAK1 deficiency prevents the formation of KRASG12D-induced pancreatic tumors, and we established that JAK1 is essential for the constitutive activation of STAT3 whose activation is a prominent characteristic of PDAC. We identified C/EBPd as a biologically relevant downstream target of JAK1 signaling, which is upregulated in human PDAC. Reinstating the expression of C/EBPd was sufficient to rescue the growth of JAK1-deficient tumorspheres. Collectively, the findings of this study suggest that JAK1 executes important functions of inflammatory cytokines through C/EBPd and may serve as a molecular target for PDAC prevention and treatment. Overall design: Comparative gene expression profiling analysis of RNA-seq data forsix isogenic pairs of mouse pancreatic cancer cell lines before and after Cre-mediated deletion of JAK1.
Sample: 53371 (WT)
SAMN33724567 • SRS17007149 • All experiments • All runs
Organism: Mus musculus
Library:
Name: GSM7092431
Instrument: NextSeq 500
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: PAIRED
Construction protocol: RNA was harvested using Rneasy mini plus kit (Qiagen). Total RNA was extracted from flash-frozen cultured cancer cells using the RNeasy Mini Kit (QIAGEN). QIAGEN's protocol was followed to extract the total RNA. The concentration of the RNA was determined on a NanoDrop spectrophotometer, and the integrity of the RNA was validated using gel electrophoresis. Quality and quantity of the total RNA was re-confirmed by Novogene. Only high quality RNA was used for library prepration. 1.3 ug of total RNA was used for the construction of sequencing libraries. Library construction was performed by Novogene with the following procedure: After the QC, mRNA was enriched using oligo(dT) beads. Next, the mRNA was fragmented randomly by adding fragmentation buffer, followed by cDNA was synthesis using mRNA template and random hexamer primers. Next a custom second-strand synthesis buffer (Illumina) , dNTPs, RNase H and DNA polymerase I were added to initiate the second-strand synthesis. After a series of terminal repair, A ligation and sequencing adaptor ligation, the double-stranded cDNA library was completed through size selection and PCR enrichment. The quality of the library was confirmed via: (1) Qubit 2.0: tests the library concentration preliminarily. (2) Agilent 2100: tests the insert size. (3) Q-PCR: quantifies the library effective concentration precisely.
Runs: 1 run, 16.6M spots, 2.5G bases, 903.6Mb
Run# of Spots# of BasesSizePublished
SRR2381627816,587,4132.5G903.6Mb2024-06-26

ID:
26936906

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...